Copyright Reports & Markets. All rights reserved.

Global Human DNA Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Human DNA Vaccines Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Type I
      • 1.2.2 Type II
    • 1.3 Market Analysis by Applications
      • 1.3.1 Influenza
      • 1.3.2 Human Papillomavirus
      • 1.3.3 HIV
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Inovio Pharmaceuticals
      • 2.1.1 Business Overview
      • 2.1.2 Human DNA Vaccines Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Inovio Pharmaceuticals Human DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 GeneOne Life Science
      • 2.2.1 Business Overview
      • 2.2.2 Human DNA Vaccines Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 GeneOne Life Science Human DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 MedImmune
      • 2.3.1 Business Overview
      • 2.3.2 Human DNA Vaccines Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 MedImmune Human DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Immunomic Therapeutics
      • 2.4.1 Business Overview
      • 2.4.2 Human DNA Vaccines Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Immunomic Therapeutics Human DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Astellas Pharma
      • 2.5.1 Business Overview
      • 2.5.2 Human DNA Vaccines Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Astellas Pharma Human DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Pharos Biologicals
      • 2.6.1 Business Overview
      • 2.6.2 Human DNA Vaccines Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Pharos Biologicals Human DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Sanofi
      • 2.7.1 Business Overview
      • 2.7.2 Human DNA Vaccines Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Sanofi Human DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Hoffmann-La Roche
      • 2.8.1 Business Overview
      • 2.8.2 Human DNA Vaccines Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Hoffmann-La Roche Human DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 CureVac
      • 2.9.1 Business Overview
      • 2.9.2 Human DNA Vaccines Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 CureVac Human DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Boehringer Ingelheim
      • 2.10.1 Business Overview
      • 2.10.2 Human DNA Vaccines Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Boehringer Ingelheim Human DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Human DNA Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Human DNA Vaccines Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Human DNA Vaccines Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Human DNA Vaccines Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Human DNA Vaccines Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Human DNA Vaccines Market Analysis by Regions

    • 4.1 Global Human DNA Vaccines Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Human DNA Vaccines Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Human DNA Vaccines Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 4.3 Europe Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 4.5 South America Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Human DNA Vaccines Sales and Growth Rate (2014-2019)

    5 North America Human DNA Vaccines by Country

    • 5.1 North America Human DNA Vaccines Sales, Revenue and Market Share by Country
      • 5.1.1 North America Human DNA Vaccines Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Human DNA Vaccines Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 5.3 Canada Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Human DNA Vaccines Sales and Growth Rate (2014-2019)

    6 Europe Human DNA Vaccines by Country

    • 6.1 Europe Human DNA Vaccines Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Human DNA Vaccines Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Human DNA Vaccines Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 6.3 UK Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 6.4 France Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 6.5 Russia Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 6.6 Italy Human DNA Vaccines Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Human DNA Vaccines by Country

    • 7.1 Asia-Pacific Human DNA Vaccines Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Human DNA Vaccines Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Human DNA Vaccines Revenue and Market Share by Country (2014-2019)
    • 7.2 China Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 7.3 Japan Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 7.4 Korea Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 7.5 India Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Human DNA Vaccines Sales and Growth Rate (2014-2019)

    8 South America Human DNA Vaccines by Country

    • 8.1 South America Human DNA Vaccines Sales, Revenue and Market Share by Country
      • 8.1.1 South America Human DNA Vaccines Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Human DNA Vaccines Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Human DNA Vaccines Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Human DNA Vaccines by Countries

    • 9.1 Middle East and Africa Human DNA Vaccines Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Human DNA Vaccines Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Human DNA Vaccines Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Human DNA Vaccines Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Human DNA Vaccines Sales and Growth Rate (2014-2019)

    10 Global Human DNA Vaccines Market Segment by Type

    • 10.1 Global Human DNA Vaccines Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Human DNA Vaccines Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Human DNA Vaccines Revenue and Market Share by Type (2014-2019)
    • 10.2 Type I Sales Growth and Price
      • 10.2.1 Global Type I Sales Growth (2014-2019)
      • 10.2.2 Global Type I Price (2014-2019)
    • 10.3 Type II Sales Growth and Price
      • 10.3.1 Global Type II Sales Growth (2014-2019)
      • 10.3.2 Global Type II Price (2014-2019)

    11 Global Human DNA Vaccines Market Segment by Application

    • 11.1 Global Human DNA Vaccines Sales Market Share by Application (2014-2019)
    • 11.2 Influenza Sales Growth (2014-2019)
    • 11.3 Human Papillomavirus Sales Growth (2014-2019)
    • 11.4 HIV Sales Growth (2014-2019)

    12 Human DNA Vaccines Market Forecast (2019-2024)

    • 12.1 Global Human DNA Vaccines Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Human DNA Vaccines Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Human DNA Vaccines Market Forecast (2019-2024)
      • 12.2.2 Europe Human DNA Vaccines Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Human DNA Vaccines Market Forecast (2019-2024)
      • 12.2.4 South America Human DNA Vaccines Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Human DNA Vaccines Market Forecast (2019-2024)
    • 12.3 Human DNA Vaccines Market Forecast by Type (2019-2024)
      • 12.3.1 Global Human DNA Vaccines Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Human DNA Vaccines Market Share Forecast by Type (2019-2024)
    • 12.4 Human DNA Vaccines Market Forecast by Application (2019-2024)
      • 12.4.1 Global Human DNA Vaccines Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Human DNA Vaccines Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Scope of the Report:
      The worldwide market for Human DNA Vaccines is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Human DNA Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Inovio Pharmaceuticals
      GeneOne Life Science
      MedImmune
      Immunomic Therapeutics
      Astellas Pharma
      Pharos Biologicals
      Sanofi
      Hoffmann-La Roche
      CureVac
      Boehringer Ingelheim

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Type I
      Type II

      Market Segment by Applications, can be divided into
      Influenza
      Human Papillomavirus
      HIV

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Human DNA Vaccines product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Human DNA Vaccines, with price, sales, revenue and global market share of Human DNA Vaccines in 2017 and 2018.
      Chapter 3, the Human DNA Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Human DNA Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Human DNA Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Human DNA Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now